Skip to content

FAL1 facilitates cisplatin resistance of lung adenocarcinoma via BMI1/BIM-mediated apoptosis–autophagy interaction

Jul 2026 · Molecular and Cellular Biochemistry · Vol 481, pp. 3945 - 3959 · 0 citations · 55 references
Medicine

TL;DR

It is demonstrated that FAL1 drives cisplatin resistance in LUAD by shifting the balance between apoptosis and autophagy through the BMI1/BIM axis.

View source

Similar papers

Open access Sep 2026

ZUP1 contributes to cisplatin resistance and treg-related signaling in non–small cell lung cancer

ZUP1 contributes to the maintenance of cisplatin-resistant growth and is associated with enhanced Treg-related immunosuppressive signaling in NSCLC and may serve as a preliminary natural-product lead for further target- validation and combination studies.

Wan Xiong, Zhi-Xuan Deng, Fang-Yong Ding et al. · 0 citations
Open access Jul 2026

IDO1 Silencing Enhances Cisplatin Sensitivity in Gastric Cancer Cells via Modulation of Apoptosis and Oxidative Stress

identifies IDO1 as a key regulator of oxidative stress-associated, caspase-dependent apoptosis in gastric cancer and suggests that targeting IDO1 in combination with platinum-based chemotherapy represents a promising strategy to enhance the efficacy of gastric cancer treatment.

Negar Taghavi Pourianazar, Narin Abdullah, A. Ilvan · 0 citations
Open access Sep 2026

The MAZ-POLD1 Signaling Axis Drives Cisplatin Resistance in Bladder Cancer by Activating DNA Damage Repair

This study verified that POLD1 was markedly overexpressed in cisplatin-resistant BC tissues and cells and demonstrated that POLD1 knockdown remarkably impaired DDR capacity in cisplatin-resistant BC cells and restored their chemosensitivity to cisplatin in vitro.

Biao Zhang, Hong Chang, Cheng Wang et al. · 0 citations
Sep 2026

Birinapant enhances cisplatin sensitivity in epithelial ovarian cancer through modulation of apoptotic and survival signaling pathways

The findings suggest that TNF-α responsiveness, cIAP1 (BIRC2)-related signaling, and the ability of cancer cells to activate apoptotic pathways, particularly caspase-8, may serve as potential biomarkers for identifying tumors more likely to respond to Birinapant-based combination therapies.

Elham Shahnazi, Arman Rostamlou, Aras Gezer et al. · 0 citations
Open access Jul 2026

SLC7A11 suppresses paclitaxel resistance and improves survival via the KLF2 regulatory axis associated with autophagy in ovarian cancer

In vivo studies showed that SLC7A11 suppressed tumor growth and overcame paclitaxel resistance in OC, accompanied by upregulated autophagy-related markers (LC3B, LC3B-II/I, and LAMP1), which underscore the significance of the SLC7A11/KLF2-autophagy regulatory axis in OC paclitaxel resistance.

Xiao-Ying Chen, Yao Ke, Shan-Zhou Xie et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.